Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Rhinology ; 61(4): 290-296, 2023 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-37083127

RESUMO

BACKGROUND: Idiopathic rhinitis (IR), previously known as vasomotor rhinitis (VMR), is the most common type of non-allergic rhinitis (NAR) which affects around 100 million people worldwide. The treatment of patients with IR is not standardized. Intranasal antihistamines (INAH) are potent drugs in the treatment of allergic rhinitis but are frequently prescribed in the treatment of IR. This systematic review of the literature and meta-analysis aims to assess the effects of INAH on IR. METHODOLOGY: A comprehensive review of the literature was conducted on Medline, Embase and Cochrane library. Randomized, controlled trials and non-randomized comparative parallel group trials comparing INAH to placebo or different INAHs were included. The primary outcome was the change in disease specific quality of life questionnaires, total nasal symptom score (TNSS). The secondary outcomes were other reported nasal symptom scores, individual symptom scores and adverse events. RESULTS: Six trials out of 987 assessing a total of 675 participants were deemed relevant for inclusion. Compared to placebo, INAH decreased total nasal symptom scores. One study also reported reduction of symptoms recorded on a visual analogue scale. There was no difference between the INAHs in terms of efficacy. Bitter taste sensation was the most frequently reported adverse event. CONCLUSIONS: INAHs seem to have benefit over placebo on nasal symptoms improvement in the treatment of NAR. No superiority between INAHs was identified.


Assuntos
Rinite Alérgica , Rinite , Humanos , Rinite/tratamento farmacológico , Qualidade de Vida , Antagonistas dos Receptores Histamínicos/uso terapêutico , Administração Intranasal , Rinite Alérgica/tratamento farmacológico
2.
J Laryngol Otol ; 113(5): 473-4, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10505166

RESUMO

Development of vocal fold paralysis in the presence of thyroid disease is strongly indicative of thyroid cancer, and requires surgical exploration. At the same time, vocal fold paralysis does not relieve the surgeon of his obligation to identify and preserve the recurrent laryngeal nerves, since the cause of the paralysis may be a benign disease, with a fair chance of functional recovery after surgery. We hereby report a case of recurrent laryngeal nerve palsy secondary to a multinodular goitre.


Assuntos
Bócio Nodular/complicações , Paralisia das Pregas Vocais/etiologia , Idoso , Bócio Nodular/diagnóstico por imagem , Bócio Nodular/cirurgia , Humanos , Masculino , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA